antidepressant

Man on chair with head in hand
Biotech

Supernus links depression drug to fast responses in ph. 2 trial

Supernus linked its mTORC1 drug to improvements in MDD, pointing to one possible path forward as it heads toward phase 2b data in another indication.
Nick Paul Taylor Oct 18, 2024 9:17am
sleep insomnia clock depression sad

J&J's oral add-on aces phase 3 in major depressive disorder

May 29, 2024 11:55am
medicine pills

NRx keeps antidepressant's blockbuster hopes alive despite flop

Apr 30, 2024 11:16am
pills prescription

Neurocrine-Takeda antidepressant hits main mark in phase 2 trial

Apr 23, 2024 10:44am
graphic image of five staffers leaving a door labeled closed below a sign labeled jobs

Eliem axes depression drug, lays off 55% of team to stretch cash

Feb 10, 2023 6:00am
success failure signposts

Relmada rails against 'implausible' phase 3 depression data

Dec 8, 2022 8:55am